PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Ophthalmology, Visual and Anatomical Sciences / Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI, USA.\', \'Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.\', \'Eye Program, Board of Governors Regenerative Medicine Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.\', \'Eye Program, Board of Governors Regenerative Medicine Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: Ljubimov@csmc.edu.\', \'Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: VArumugaswami@mednet.ucla.edu.\', \'Department of Ophthalmology, Visual and Anatomical Sciences / Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI, USA. Electronic address: akuma@med.wayne.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1542-0124(21)00106-310.1016/j.jtos.2021.09.007
?:doi
?:hasPublicationType
?:journal
  • The ocular surface
is ?:pmid of
?:pmid
?:pmid
  • 34583089
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 and its beta variant of concern infect human conjunctival epithelial cells and induce differential antiviral innate immune response.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all